HC Wainwright & Co. Reiterates Buy on MediWound, Maintains $28 Price Target
Portfolio Pulse from Benzinga Newsdesk
HC Wainwright & Co. has reiterated its Buy rating on MediWound (NASDAQ:MDWD) and maintained a price target of $28.
July 16, 2024 | 12:29 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
HC Wainwright & Co. has reiterated its Buy rating on MediWound and maintained a price target of $28, indicating confidence in the company's future performance.
The reiteration of a Buy rating and a maintained price target of $28 by a reputable analyst firm like HC Wainwright & Co. is a positive signal for investors. It suggests confidence in MediWound's future performance and could lead to increased investor interest and a potential short-term price increase.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100